
Biomerieux SA
PAR:BIM

Intrinsic Value
The intrinsic value of one
BIM
stock under the Base Case scenario is
112.11
EUR.
Compared to the current market price of 115.5 EUR,
Biomerieux SA
is
Overvalued by 3%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Biomerieux SA
Fundamental Analysis


Revenue & Expenses Breakdown
Biomerieux SA
Balance Sheet Decomposition
Biomerieux SA
Current Assets | 2.5B |
Cash & Short-Term Investments | 234.5m |
Receivables | 1B |
Other Current Assets | 1.3B |
Non-Current Assets | 3.3B |
Long-Term Investments | 195.8m |
PP&E | 1.7B |
Intangibles | 1.2B |
Other Non-Current Assets | 155.1m |
Free Cash Flow Analysis
Biomerieux SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Biomerieux SA
Revenue
|
4B
EUR
|
Cost of Revenue
|
-1.8B
EUR
|
Gross Profit
|
2.2B
EUR
|
Operating Expenses
|
-1.6B
EUR
|
Operating Income
|
611.7m
EUR
|
Other Expenses
|
-179.5m
EUR
|
Net Income
|
432.2m
EUR
|
BIM Profitability Score
Profitability Due Diligence
Biomerieux SA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Score
Biomerieux SA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
BIM Solvency Score
Solvency Due Diligence
Biomerieux SA's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Score
Biomerieux SA's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIM Price Targets Summary
Biomerieux SA
According to Wall Street analysts, the average 1-year price target for
BIM
is 129.54 EUR
with a low forecast of 90.9 EUR and a high forecast of 147 EUR.
Dividends
Current shareholder yield for BIM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
BIM
stock under the Base Case scenario is
112.11
EUR.
Compared to the current market price of 115.5 EUR,
Biomerieux SA
is
Overvalued by 3%.